March 28, 2026 15:00 ET | Source: Roivant Sciences The results of the Phase 3 VALOR trial were published in…
“Persistent kidney inflammation is a hallmark of IgAN, and a key driver of disease progression, leading to ongoing kidney damage…
RALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Wake Radiology UNC Health Rex is proud to announce that Chief Operating…
Study Confirms Long-Acting Treatment is Effective among People Living with HIV Who Experience Challenges Taking Daily Oral Treatment February 18,…
Austin-Based Healthcare Technology Provider Recognized for Community Impact, Life-Saving Solutions that Protect Patients, Healthcare Workers December 15, 2025 10:55 ET…
AGOURA HILLS, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) in collaboration with the Brush and Key…
NEW DELHI, Oct. 31, 2025 /PRNewswire/ -- The day long Journal Development Symposium 2025, organised by Springer Nature, brought together…
Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response…
Nearly all participants (11 of 12) experienced clinically meaningful hearing improvements, including three who achieved normal hearing; eight with longer…
NORWALK, Conn., Sept. 22, 2025 /PRNewswire/ -- The Wall Street Journal recently featured GameChange Solar in an article on Saudi Arabia's…